COVID-19 interventions have proven effective in reducing COVID-19 transmission, though there still remains many barriers to ensure effective prevention of COVID-19. Prof. Renslow Sherer (The University of Chicago Medicine, Chicago, IL, USA) joins touchINFECTIOUS DISEASES to discuss the these interventions. Prof. Sherer also discusses the future steps in optimizing COVID-19 care and what needs to be done to improve patient education regarding vaccination and reducing transmission.
View more content from Dr Renslow Sherer: Long-term efficacy of mRNA vaccines in COVID-19, and the evidence in favour of booster vaccinations
The presentation entitled: ‘COVID-19 Update Part 1: Prevention’ was presented at the American Conference for the Treatment of HIV (ACTHIV), May 5-7, 2022.
- What have we learned from recent epidemiology studies of COVID-19? (0:05)
- What interventions are proven to reduce transmission of COVID-19? (1:52)
- What barriers to effective COVID prevention are evolving? (3:42)
- What steps should be taken in the future to optimize care? (5:36)
- How can we improve patient education regarding vaccination? (8:27)
Disclosures: Renslow Sherer receives grant/research support from Gilead Sciences
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Access further resources from Prof. Renslow Sherer: Lessons in Resilience – What HIV Teaches Us About COVID-19
Share this Video
Related Videos In COVID-19
Molnupiravir, an oral antiviral against SARS-CoV-2: Chris Butler, ECCMID 2023
Molnupiravir, an oral antiviral against SARS-CoV-2 was first granted emergency use authorisation in 2021 to reduce the risk of hospitalisation and death in mild to moderate COVID-19 with increased risk of developing severe disease. We were delighted to speak with Prof. Chris Butler (University of Oxford, Oxford, UK) to discuss the mechanism of action of […]
PANORAMIC trial – Molnupiravir efficacy in adults with COVID-19 at increased risk of adverse outcomes: Chris Butler, ECCMID 2023
PANORAMIC (ISRCTN30448031) was a multicentre, open-label, randomized controlled trial investigating novel treatments for COVID-19 in the UK. We were delighted to speak with Prof. Chris Butler (University of Oxford, Oxford, UK) to discuss the PANORAMIC study results, and how these insights will optimise the use of molnupiravir in clinical practice. Catch up: Interview with Prof. […]
COVID-19 vaccine development, updates and advances: Christoph Spinner, ECCMID 2023
The COVID-19 pandemic brought about the accelerated development of vaccinations to protect against variants of SARS-CoV-2, recently new targets of broad protection against potential future variants have been outlined and numerous vaccine candidates are in pre-clinical and clinical development. It was a pleasure to speak with Editorial Board member Dr. Christoph Spinner (Technical University of […]